A double blind, placebo controlled 2-way cross-over study to assess the clitoral engorgement response as measured by non-contrast magnetic resonance imaging (MRI) in women with female sexual arousal disorder (FSAD) when administered a single dose of sildenafil (100mg) followed by audio/visual sexual stimulation

Trial Profile

A double blind, placebo controlled 2-way cross-over study to assess the clitoral engorgement response as measured by non-contrast magnetic resonance imaging (MRI) in women with female sexual arousal disorder (FSAD) when administered a single dose of sildenafil (100mg) followed by audio/visual sexual stimulation

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Apr 2008

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top